Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Article
  • Published:

Enabling topical immunization via microporation: a novel method for pain-free and needle-free delivery of adenovirus-based vaccines

Gene Therapy volume 10, pages 251–260 (2003)Cite this article

Abstract

The skin represents an excellent site for vaccine inoculation due to its natural role as a first line of contact with foreign pathogens and the high local frequency of antigen presenting cells. To facilitate skin-directed immunization, a new technique has been developed (termed microporation) whereby a vaporization process is used to remove tiny areas of the stratum corneum creating microscopic pores that allow access to the underlying viable epidermis. Reporter gene expression was 100-fold increased following application of an adenovirus vector to microporated skin when compared to intact skin. Furthermore, 10–100-fold greater cellular and humoral immune responses were observed following topical administration of an adenovirus vaccine to microporated skin versus intact skin. Hairless mice responded to the microporated adenovirus vaccine equivalently to mice with normal hair follicle distribution demonstrating the activity of the microporated vaccine was not related to follicle count. In a tumor challenge model using a surrogate antigen, microporation increased vaccine efficacy by approximately 100-fold compared to intact skin. Finally, microporation enabled delivery of an adenovirus vaccine carrying a relevant melanoma antigen resulting in the development of auto-immune vitiligo and tumor protection. Thus, the microporation technology has proven to be a reliable and easy method to enable skin-directed vaccination.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9

Similar content being viewed by others

References

  1. Spellberg B . The cutaneous citadel: a holistic view of skin and immunity. Life Sci 2000; 67: 477–502.

    Article  CAS  PubMed  Google Scholar 

  2. Wan Y et al. Dendritic cells transduced with an adenoviral vector encoding a model tumor-associated antigen for tumor vaccination. Hum Gene Ther 1997; 8: 1355–1363.

    Article  CAS  PubMed  Google Scholar 

  3. Perricone MA et al. Immunogene therapy for murine melanoma using recombinant adenoviral vectors expressing melanoma-associated antigens. Mol Ther 2000; 1: 275–284.

    Article  CAS  PubMed  Google Scholar 

  4. Forg P, von Hoegen P, Dalemans W, Schirrmacher V . Superiority of the ear pinna over muscle tissue as site for DNA vaccination. Gene Ther 1998; 5: 789–797.

    Article  CAS  PubMed  Google Scholar 

  5. Smith A et al. Fluorescein kinetics in interstitial fluid harvested from diabetic skin during fluorescein angiography: implications for glucose monitoring. Diabetes Technol Therapeutics 1999; 1: 21–27.

    Article  CAS  Google Scholar 

  6. Barry BW . Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci 2001; 14: 101–114.

    Article  CAS  PubMed  Google Scholar 

  7. McAllister DV, Allen MG, Prausnitz MR . Microfabricated microneedles for gene and drug delivery. Ann Rev Biomed Eng 2000; 2: 289–313.

    Article  CAS  Google Scholar 

  8. Chen D et al. Epidermal immunization by a needle-free powder delivery technology: immunogenicity of influenza vaccine and protection in mice. Nat Med 2000; 6: 1187–1190.

    Article  CAS  PubMed  Google Scholar 

  9. Haensler J et al. Intradermal DNA immunization by using jet-injectors in mice and monkeys. Vaccine 1999; 17: 628–638.

    Article  CAS  PubMed  Google Scholar 

  10. Misra A, Ganga S, Upadhyay P . Needle-free, non-adjuvanted skin immunization by electroporation-enhanced transdermal delivery of diphtheria toxoid and a candidate peptide vaccine against hepatitis B virus. Vaccine 1999; 18: 517–523.

    Article  CAS  PubMed  Google Scholar 

  11. Wan Y et al. Genetically modified dendritic cells prime autoreactive T cells through a pathway independent of CD40L and interleukin 12: implications for cancer vaccines. Cancer Res 2000; 60: 3247–3253.

    CAS  PubMed  Google Scholar 

  12. Hitt MM, Addison CL, Graham FL . Human adenovirus vectors for gene transfer into mammalian cells. Adv Pharmacol 1997; 40: 137–206.

    Article  CAS  PubMed  Google Scholar 

  13. Fan H, Lin Q, Morrissey GR, Khavari PA . Immunization via hair follicles by topical application of naked DNA to normal skin. Nat Biotechnol 1999; 17: 870–872.

    Article  CAS  PubMed  Google Scholar 

  14. Tang DC, Shi Z, Curiel DT . Vaccination onto bare skin. Nature 1997; 388: 729–730.

    Article  CAS  PubMed  Google Scholar 

  15. Shi Z et al. Protection against tetanus by needle-free inoculation of adenovirus- vectored nasal and epicutaneous vaccines. J Virol 2001; 75: 11 474–11 482.

    Article  Google Scholar 

  16. Banga AK . Electrically Assisted Transdermal and Topical Drug Delivery. Taylor & Francis: London, 1998.

    Google Scholar 

  17. Bramson JL, Wan YH . The efficacy of genetic vaccination is dependent upon the nature of the vector system and antigen. Expert Opin Biol Ther 2002; 2: 75–85.

    Article  CAS  PubMed  Google Scholar 

  18. Steitz J et al. Genetic immunization of mice with human tyrosinase-related protein 2: implications for the immunotherapy of melanoma. Int J Cancer 2000; 86: 89–94.

    Article  CAS  PubMed  Google Scholar 

  19. Bowne WB et al. Coupling and uncoupling of tumor immunity and autoimmunity. J Exp Med 1999; 190: 1717–1722.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Steitz J, Bruck J, Knop J, Tuting T . Adenovirus-transduced dendritic cells stimulate cellular immunity to melanoma via a CD4(+) T cell-dependent mechanism. Gene Ther 2001; 8: 1255–1263.

    Article  CAS  PubMed  Google Scholar 

  21. Overwijk WW et al. Vaccination with a recombinant vaccinia virus encoding a “self” antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes. Proc Natl Acad Sci USA 1999; 96: 2982–2987.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Pardoll DM . Inducing autoimmune disease to treat cancer. Proc Natl Acad Sci USA 1999; 96: 5340–5342.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Chen PW et al. Therapeutic antitumor response after immunization with a recombinant adenovirus encoding a model tumor-associated antigen. J Immunol 1996; 156: 224–231.

    CAS  PubMed  Google Scholar 

  24. Zhai Y et al. Antigen-specific tumor vaccines. Development and characterization of recombinant adenoviruses encoding MART1 or gp100 for cancer therapy. J Immunol 1996; 156: 700–710.

    CAS  PubMed  Google Scholar 

  25. Hirschowitz EA et al. Adenovirus-mediated expression of melanoma antigen gp75 as immunotherapy for metastatic melanoma. Gene Ther 1998; 5: 975–983.

    Article  CAS  PubMed  Google Scholar 

  26. Glenn GM et al. Transcutaneous immunization: a human vaccine delivery strategy using a patch. Nat Med 2000; 6: 1403–1406.

    Article  CAS  PubMed  Google Scholar 

  27. Glenn GM, Rao M, Matyas GR, Alving CR . Skin immunization made possible by cholera toxin. Nature 1998; 391: 851.

    Article  CAS  PubMed  Google Scholar 

  28. Chen D et al. Epidermal powder immunization induces both cytotoxic T-lymphocyte and antibody responses to protein antigens of influenza and hepatitis B viruses. J Virol 2001; 75: 11 630–11 640.

    Article  Google Scholar 

  29. Ng P et al. An enhanced system for construction of adenoviral vectors by the two-plasmid rescue method. Hum Gene Ther 2000; 11: 693–699.

    Article  CAS  PubMed  Google Scholar 

  30. Bramson J et al. Construction of a double recombinant adenovirus vector expressing a heterodimeric cytokine: in vitro and in vivo production of biologically active interleukin-12. Hum Gene Ther 1996; 7: 333–342.

    Article  CAS  PubMed  Google Scholar 

  31. Bramson JL, Hitt M, Gauldie J, Graham FL . Pre-existing immunity to adenovirus does not prevent tumor regression following intratumoral administration of a vector expressing IL-12 but inhibits virus dissemination. Gene Ther 1997; 4: 1069–1076.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

JLB is supported by an Rx & D–Health Research Foundation/CIHR Career Award in Health Research.

Author information

Authors and Affiliations

  1. Department of Pathology and Molecular Medicine, Center for Gene Therapeutics, McMaster University, Hamilton, Ontario, Canada

    J Bramson, K Dayball, C Evelegh & Y H Wan

  2. Elan Pharmaceutical Technologies, Trinity College, Dublin, Ireland

    D Page

  3. Altea Genomics, Inc., Atlanta, GA, USA

    A Smith

Authors
  1. J Bramson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K Dayball
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C Evelegh
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Y H Wan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D Page
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bramson, J., Dayball, K., Evelegh, C. et al. Enabling topical immunization via microporation: a novel method for pain-free and needle-free delivery of adenovirus-based vaccines. Gene Ther 10, 251–260 (2003). https://doi.org/10.1038/sj.gt.3301886

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3301886

Keywords

This article is cited by

Search

Advanced search

Quick links